Qualigen Therapeutics, Inc. Received Nasdaq Notice of a Delisting Determination tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.
The final week of May, though shortened by a holiday, is still packed with key earnings reports from various sectors, including Salesforce (CRM), Costco Wholesa
Qualigen Therapeutics, Inc. (NASDAQ:QLGN – Get Free Report) rose 6.1% during trading on Friday . The stock traded as high as $0.33 and last traded at $0.31. Approximately 331,562 shares traded hands during mid-day trading, an increase of 338% from the average daily volume of 75,700 shares. The stock had previously closed at $0.29. Qualigen […]
Qualigen Therapeutics' (QLGN) Novel Direct Pan-RAS Inhibitors Presented at AACR streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Poster Includes Preclinical Data on Novel Direct Pan-RAS Inhibitors CARLSBAD, Calif., April 10, 2024 (GLOBE NEWSWIRE) Qualigen Therapeutics, Inc. (“Qualigen” or “the Company,” Nasdaq: QLGN) today announces a poster presentation on its preclinical Novel Direct Pan-RAS Inhibitors was presented at the American Association for Cancer Research (AACR) Annual Meeting 2024 held April 5 – 10 in San Diego, California. “We continue to see cancers developing resistance to current clinical agents that tar